Catalyst Wire Dossier Catalyst Wire Dossier

Val-mCyd

Val-mCyd · Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Val-mCyd, covering 2016-04-27 to 2016-04-27. Get the full timeline:

Most recent: Clinical Trial Update: Dose Escalation Study to Evaluate the Safety and Antiviral Activity of Val-mCyd in Adults With Chronic Hepatitis C [Phase 1, Phase 2]

See pricing